单倍体造血干细胞移植后输注的记忆T细胞持续存在并高度扩增
该研究对19例接受单倍体造血干细胞移植后输注CD45RA去除供者淋巴细胞输注的患者进行淋巴细胞纵向分析,T细胞受体测序显示输注的记忆T细胞克隆显著扩增而非克隆多样性增加,病原特异性记忆T细胞包括CMV特异性细胞植入并持续至少1个月,多数患者出现强效多功能CMV特异性T细胞应答。
要点
- CD45RA去除供者淋巴细胞输注不增加T细胞克隆多样性,而是导致输注的记忆T细胞克隆显著扩增。
- 病原特异性记忆T细胞包括CMV特异性细胞植入并持续至少1个月。
- 多数患者出现强效多功能CMV特异性T细胞应答,其扩增与供者CMV特异性细胞频率相关。
核心结论
- CD45RA去除供者淋巴细胞输注后记忆T细胞克隆显著扩增,病原特异性记忆T细胞植入并持续,为病毒感染的免疫保护提供依据。
研究设计与样本
- 对19例既往入组II期前瞻性临床试验(NCT04687982)并接受单倍体造血干细胞移植后CD45RA去除供者淋巴细胞输注的患者进行淋巴细胞纵向分析。
主要发现
- T细胞受体测序显示CD45RA去除供者淋巴细胞输注不增加T细胞克隆多样性,而是导致部分输注的记忆T细胞克隆显著扩增。
- 病原特异性记忆T细胞包括CMV特异性细胞植入并持续至少1个月。
- 深度免疫表型分析显示多数患者出现强效多功能效应CMV特异性T细胞应答,其扩增与供者CMV特异性细胞频率相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplant cyclophosphamide is a curative treatment for many hematological malignancies, yet a majority of patients still suffers from recurrent infections. Post-transplant infusion of memory T-cells could potentially enhance immunological protection without increasing the risk of eliciting acute graft-versus-host disease, which is mainly induced by naïve T-cells. Here, we performed longitudinal analysis of the lymphocyte compartment in 19 patients who underwent haplo-HSCT previously enrolled in a phase II prospective clinical trial (www.clinicaltrials.gov as #NCT04687982), in which they received post-transplant CD45RA-depleted donor lymphocyte infusions (DLI). T-cell receptor sequencing analysis showed that, surprisingly, CD45RA-depleted DLI do not increase T-cell clonal diversity, but lead to prominent expansion of a selected number of infused memory T-cell clones, suggesting recruitment of these cells in the immune response. Pathogen-specific memory T-cells, including cytomegalovirus (CMV)-specific cells, were engrafted and were able to persist for at least 1 month. Deep immunophenotyping revealed strong polyfunctional effector CMV-specific T-cell responses in the majority of patients, with their expansion correlating with the frequency of CMV-specific cells in the donor. These findings provide a rationale behind the suggested improved protection against viral infections in patients receiving CD45RA-depleted DLI.
引用
- van Beek JJP, Puccio S, Di Vito C, et al. Selected memory T cells infused post-haploidentical hematopoietic stem cell transplantation persist and hyperexpand. Blood Adv. 2023. PMID: 36469095. doi:10.1182/bloodadvances.2022007735
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。